CNET

A New Study Found That Weight-Loss Drugs Like Ozempic Could Lower Your Heart Attack Risk

Regardless of how much weight you lose, GLP-1 drugs like Wegovy and Ozempic could decrease major adverse cardiovascular events.
Fierce Biotech

Ventyx's CV drug reduces cardio risk biomarker by nearly 80% in 1st week of phase 2 study

The San Diego-based biotech has been evaluating the oral NLRP3 inhibitor, dubbed VTX3232, in a phase 2 study of 175 patients ...

Ventyx surges on mid-stage trial data for heart disease drug

Ventyx Biosciences (VTYX) stock soar as the company announces data from a Phase 2 trial showing the potential of its cardiovascular drug VTX3232. Read more here.

Anti-obesity drugs have heart health benefits beyond weight loss, study finds

The findings suggest weight loss drugs independently affect heart health risks, researchers said. View on euronews ...

Study compares antidepressant side effects, finding changes in weight, heart rate and more vary widely

In the study, published Tuesday in the journal The Lancet, researchers analyzed more than 58,000 participants to compare 30 ...
IEEE

Dynamic Estimation of Cardiovascular State From Arterial Blood Pressure Recordings

Abstract: Real-time estimation of patient cardiovascular states, including cardiac output and systemic vascular resistance, is necessary for personalized hemodynamic monitoring and management. Highly ...
The Lancet

Cardioprotective glucose-lowering drugs, statins, and risk of first-time atherosclerotic cardiovascular disease in Denmark: a nationwide cohort study

aDepartment of Clinical Biochemistry, Copenhagen University Hospital - Herlev and Gentofte, Denmark bThe Copenhagen General Population Study, Copenhagen University Hospital - Herlev and Gentofte, ...